Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature

By Pinto Evelin   Pinelo Sueli   Osório Marta   Ferreira Carla   Serra Helena   Pires Ilda   Barbosa António   Figueiredo Helena   Felgueira Eduarda   Tavares Angelina  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 545-548

Informa Healthcare

Access to resources Recommend Favorite

Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist

By Vani Susheel   McDonald Sarah E.   Williams Alistair R.W.   Mason J. Ian   Thong K. Joo   Critchley Hilary O.D.  

Human Reproduction, Vol. 22, Iss. 11, 2007-11 ,pp. : 2981-2991

Oxford University Press

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF

By Janssens RMJ   Vermeiden JPW   Lambalk CB   Schats R   Schoemaker J  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2386-2391

Oxford University Press

Access to resources Recommend Favorite

Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?

By Casper Robert F.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1144-1146

Oxford University Press

Access to resources Recommend Favorite